Literature DB >> 33572762

Recent Advances in the Development of Exogenous dsRNA for the Induction of RNA Interference in Cancer Therapy.

Tatiana S Golubeva1,2, Viktoria A Cherenko1,2, Konstantin E Orishchenko1,2.   

Abstract

Selective regulation of gene expression by means of RNA interference has revolutionized molecular biology. This approach is not only used in fundamental studies on the roles of particular genes in the functioning of various organisms, but also possesses practical applications. A variety of methods are being developed based on gene silencing using dsRNA-for protecting agricultural plants from various pathogens, controlling insect reproduction, and therapeutic techniques related to the oncological disease treatment. One of the main problems in this research area is the successful delivery of exogenous dsRNA into cells, as this can be greatly affected by the localization or origin of tumor. This overview is dedicated to describing the latest advances in the development of various transport agents for the delivery of dsRNA fragments for gene silencing, with an emphasis on cancer treatment.

Entities:  

Keywords:  RNA interference; cancer; delivery agents; exogenous dsRNA; oligonucleotides

Mesh:

Substances:

Year:  2021        PMID: 33572762      PMCID: PMC7865971          DOI: 10.3390/molecules26030701

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  87 in total

Review 1.  RNAi therapeutic and its innovative biotechnological evolution.

Authors:  Yuhua Weng; Haihua Xiao; Jinchao Zhang; Xing-Jie Liang; Yuanyu Huang
Journal:  Biotechnol Adv       Date:  2019-04-26       Impact factor: 14.227

2.  Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.

Authors:  P U Emeagi; S Maenhout; N Dang; C Heirman; K Thielemans; K Breckpot
Journal:  Gene Ther       Date:  2013-06-27       Impact factor: 5.250

3.  M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.

Authors:  Yeon Woong Choo; Mikyung Kang; Han Young Kim; Jin Han; Seokyung Kang; Ju-Ro Lee; Gun-Jae Jeong; Sung Pil Kwon; Seuk Young Song; Seokhyeong Go; Mungyo Jung; Jihye Hong; Byung-Soo Kim
Journal:  ACS Nano       Date:  2018-08-29       Impact factor: 15.881

4.  Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.

Authors:  Cai Li; Tianzhong Li; Linfeng Huang; Mengsu Yang; Guangyu Zhu
Journal:  Chem Asian J       Date:  2019-04-04

5.  Stiffness of cationized gelatin nanoparticles is a key factor determining RNAi efficiency in myeloid leukemia cells.

Authors:  Weiqi Zhang; Bo Han; Xinning Lai; Chen Xiao; Shilin Xu; Xianghui Meng; Zifu Li; Jie Meng; Tao Wen; Xiangliang Yang; Jian Liu; Haiyan Xu
Journal:  Chem Commun (Camb)       Date:  2020-01-03       Impact factor: 6.222

6.  Stable silencing of IGF1R using Lentiviral-mediated shRNA in HEK293T cells.

Authors:  L Nasehi; M H Ghahremani; K Yavari; J Hadjati; A Fallah; B Abdolhossein Zadeh; Z Saltanatpour
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2017-02-28       Impact factor: 1.770

7.  Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle.

Authors:  Yao Chen; Mengjiao Xu; Yi Guo; Keyao Tu; Weimin Wu; Jianjun Wang; Xiaowen Tong; Wenjuan Wu; Lifeng Qi; Donglu Shi
Journal:  Nanotechnology       Date:  2016-12-01       Impact factor: 3.874

8.  Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.

Authors:  Xin Zhao; Dong-Ming Zhu; Wen-Juan Gan; Zhi Li; Jiang-Lei Zhang; Hua Zhao; Jin Zhou; De-Chun Li
Journal:  Oncol Rep       Date:  2012-12-19       Impact factor: 3.906

9.  Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.

Authors:  Giedrius Kalesnykas; Emmi Kokki; Laura Alasaarela; Hanna P Lesch; Timo Tuulos; Kati Kinnunen; Hannu Uusitalo; Kari Airenne; Seppo Yla-Herttuala
Journal:  Curr Gene Ther       Date:  2017       Impact factor: 4.391

10.  miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.

Authors:  S-F Su; Y-W Chang; C Andreu-Vieyra; J Y Fang; Z Yang; B Han; A S Lee; G Liang
Journal:  Oncogene       Date:  2012-10-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.